PHILADELPHIA (WPVI) -- On and off rain marked the final days of the Penn Relays, where athletes battled not only competition but inclement weather during the historic event. The 129th running of ...

It affects between 6,000 and 8,000 women in the U.S. and 80,000 globally. Verastem believes Avmapki Fakzynja Co-Pack is the first-ever oral combo therapy of two novel drugs approved in oncology ...

Despite its history as a monotherapy, Blenrep proved its worth in two combo trials. In DREAMM-7, Blenrep beat Johnson & Johnson’s Darzalex in their respective pairings with Velcade and ...

According to Voigt, the eftilagimod-Keytruda combo’s value proposition lies in that it offers a potential immunotherapy-only regimen, while the standards today for PD-L1-negative patients all ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor drugs from fellow British biotech Astex Pharmaceuticals. The small ...

PHILADELPHIA (WPVI) -- On and off rain marked the final days of the Penn Relays, where athletes battled not only competition but inclement weather during the historic event.